Comparative study between Albumin and Normal saline for the management of ICU admitted critically ill patients
Not Applicable
- Conditions
- Health Condition 1: A049- Bacterial intestinal infection, unspecifiedHealth Condition 2: O- Medical and SurgicalHealth Condition 3: A419- Sepsis, unspecified organism
- Registration Number
- CTRI/2021/11/037734
- Lead Sponsor
- VIMSAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)AGE-18-70 YEARS
2)AFTER OBTAINING INFORMED CONSENT WE WILL INCLUDE ADULT PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK WITH
I)WBC LEVEL >12000 OR <4000 MILIMETERCUBE
II)HEART RATE >90/MINUTES
III)SYSTOLIC BLOOD PRESSURE <90MM HG OR MEAN ARTERIAL PRESSURE <65 MM HG
IV)URINE OUTPUT
V)LACTATE LEVEL >2 MILIEQUIVALENTS/L
2.ASA GRADE I AND II
Exclusion Criteria
1.PREGNANT WOMEN AND LACTATING MOTHERS
2.CHILDREN <14 YEARS
3.ACUTE BURN PATIENTS
4.HEART FAILURE
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO COMPARE THE EFFECTS OF ALBUMIN AND CRYSTALLOIDS ON INCIDENCE OF MORTALITY IN PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK.Timepoint: NOVEMBER 2019 TO OCTOBER 2021
- Secondary Outcome Measures
Name Time Method TO ASSESS THE TIME TO SHIFT PATIENTS TO GENERAL WARDS.Timepoint: NOVEMBER 2019 TO OCTOBER 2021